vs
Clearfield, Inc.（CLFD）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Clearfield, Inc.的1.8倍（$62.1M vs $34.3M），Clearfield, Inc.净利率更高（-1.8% vs -70.9%，领先69.1%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -3.2%），Cytek Biosciences, Inc.自由现金流更多（$-1.8M vs $-2.4M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs -3.5%）
Clearfield, Inc.总部位于美国明尼苏达州明尼阿波利斯市，是一家专注于光纤产品研发生产的企业，其产品主要应用于光纤通信网络建设领域，为通信基础设施部署提供相关硬件支撑。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
CLFD vs CTKB — 直观对比
营收规模更大
CTKB
是对方的1.8倍
$34.3M
营收增速更快
CTKB
高出11.3%
-3.2%
净利率更高
CLFD
高出69.1%
-70.9%
自由现金流更多
CTKB
多$656.0K
$-2.4M
两年增速更快
CTKB
近两年复合增速
-3.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.3M | $62.1M |
| 净利润 | $-614.0K | $-44.1M |
| 毛利率 | 33.2% | 52.9% |
| 营业利润率 | -5.3% | -9.0% |
| 净利率 | -1.8% | -70.9% |
| 营收同比 | -3.2% | 8.1% |
| 净利润同比 | 67.8% | -557.1% |
| 每股收益（稀释后） | $-0.04 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLFDCTKB
| Q4 25 | $34.3M | $62.1M | ||
| Q3 25 | $23.4M | $52.3M | ||
| Q2 25 | $49.9M | $45.6M | ||
| Q1 25 | $47.2M | $41.5M | ||
| Q4 24 | $29.7M | $57.5M | ||
| Q3 24 | $5.6M | $51.5M | ||
| Q2 24 | $48.8M | $46.6M | ||
| Q1 24 | $36.9M | $44.9M |
净利润CLFDCTKB
| Q4 25 | $-614.0K | $-44.1M | ||
| Q3 25 | $-9.1M | $-5.5M | ||
| Q2 25 | $1.6M | $-5.6M | ||
| Q1 25 | $1.3M | $-11.4M | ||
| Q4 24 | $-1.9M | $9.6M | ||
| Q3 24 | — | $941.0K | ||
| Q2 24 | $-447.0K | $-10.4M | ||
| Q1 24 | $-5.9M | $-6.2M |
毛利率CLFDCTKB
| Q4 25 | 33.2% | 52.9% | ||
| Q3 25 | 53.2% | 52.7% | ||
| Q2 25 | 30.5% | 52.3% | ||
| Q1 25 | 30.1% | 48.6% | ||
| Q4 24 | 29.2% | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | 21.9% | 54.6% | ||
| Q1 24 | 7.7% | 51.3% |
营业利润率CLFDCTKB
| Q4 25 | -5.3% | -9.0% | ||
| Q3 25 | 10.3% | -17.6% | ||
| Q2 25 | 3.0% | -23.3% | ||
| Q1 25 | 0.6% | -36.1% | ||
| Q4 24 | -6.9% | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | -4.7% | -18.3% | ||
| Q1 24 | -26.4% | -23.9% |
净利率CLFDCTKB
| Q4 25 | -1.8% | -70.9% | ||
| Q3 25 | -38.8% | -10.5% | ||
| Q2 25 | 3.2% | -12.2% | ||
| Q1 25 | 2.8% | -27.5% | ||
| Q4 24 | -6.4% | 16.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | -0.9% | -22.4% | ||
| Q1 24 | -16.0% | -13.8% |
每股收益（稀释后）CLFDCTKB
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.40 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $96.4M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $249.7M | $341.7M |
| 总资产 | $268.1M | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLFDCTKB
| Q4 25 | $96.4M | $90.9M | ||
| Q3 25 | $106.0M | $93.3M | ||
| Q2 25 | $117.2M | $75.5M | ||
| Q1 25 | $112.0M | $95.3M | ||
| Q4 24 | $113.0M | $98.7M | ||
| Q3 24 | $129.0M | $162.3M | ||
| Q2 24 | $123.8M | $177.9M | ||
| Q1 24 | $142.9M | $168.8M |
总债务CLFDCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
股东权益CLFDCTKB
| Q4 25 | $249.7M | $341.7M | ||
| Q3 25 | $256.2M | $378.6M | ||
| Q2 25 | $264.5M | $377.6M | ||
| Q1 25 | $265.9M | $379.6M | ||
| Q4 24 | $267.4M | $395.7M | ||
| Q3 24 | $275.8M | $385.5M | ||
| Q2 24 | $274.6M | $389.1M | ||
| Q1 24 | $279.2M | $392.6M |
总资产CLFDCTKB
| Q4 25 | $268.1M | $461.5M | ||
| Q3 25 | $306.2M | $494.9M | ||
| Q2 25 | $314.7M | $493.3M | ||
| Q1 25 | $310.9M | $482.6M | ||
| Q4 24 | $303.2M | $499.5M | ||
| Q3 24 | $315.3M | $491.2M | ||
| Q2 24 | $318.1M | $483.7M | ||
| Q1 24 | $315.4M | $492.1M |
负债/权益比CLFDCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $-1.8M |
| 自由现金流率自由现金流/营收 | -7.1% | -2.9% |
| 资本支出强度资本支出/营收 | 2.9% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.8M |
8季度趋势，按日历期对齐
经营现金流CLFDCTKB
| Q4 25 | $-1.4M | $-771.0K | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | $7.9M | $108.0K | ||
| Q1 25 | $3.0M | $-125.0K | ||
| Q4 24 | $7.2M | $2.0M | ||
| Q3 24 | $22.2M | $13.2M | ||
| Q2 24 | $4.0M | $6.2M | ||
| Q1 24 | $-5.7M | $4.0M |
自由现金流CLFDCTKB
| Q4 25 | $-2.4M | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | $7.5M | $-1.5M | ||
| Q1 25 | $654.0K | $-974.0K | ||
| Q4 24 | $5.1M | $1.1M | ||
| Q3 24 | $18.2M | $12.2M | ||
| Q2 24 | $2.8M | $5.2M | ||
| Q1 24 | $-7.7M | $3.4M |
自由现金流率CLFDCTKB
| Q4 25 | -7.1% | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | 15.1% | -3.2% | ||
| Q1 25 | 1.4% | -2.3% | ||
| Q4 24 | 17.1% | 1.9% | ||
| Q3 24 | 323.0% | 23.7% | ||
| Q2 24 | 5.8% | 11.0% | ||
| Q1 24 | -20.8% | 7.6% |
资本支出强度CLFDCTKB
| Q4 25 | 2.9% | 1.6% | ||
| Q3 25 | 2.0% | 1.3% | ||
| Q2 25 | 0.8% | 3.5% | ||
| Q1 25 | 5.1% | 2.0% | ||
| Q4 24 | 7.0% | 1.6% | ||
| Q3 24 | 71.4% | 2.0% | ||
| Q2 24 | 2.5% | 2.3% | ||
| Q1 24 | 5.3% | 1.3% |
现金转化率CLFDCTKB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLFD
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
